APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients for Oral Solid Dosage Forms

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Growth and Trends Forecast to 2032

23 December 2025111 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients for Oral Solid Dosage Forms Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients for Oral Solid Dosage Forms Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipients for Oral Solid Dosage Forms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Excipients for Oral Solid Dosage Forms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Excipients for Oral Solid Dosage Forms include Ashland, Associated British Foods, BASF, Croda International, Dow, Evonik, JRS Pharma, Lubrizol and Mitsubishi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Excipients for Oral Solid Dosage Forms market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Excipients for Oral Solid Dosage Forms market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Excipients for Oral Solid Dosage Forms.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Company

Ashland

Associated British Foods

BASF

Croda International

Dow

Evonik

JRS Pharma

Lubrizol

Mitsubishi

Roquette

Shin-Etsu

Südzucker AG

Hunan Er-Kang Pharmaceutical Co., Ltd.

Tianjin Chasesun Pharmaceutical Co., Ltd.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Sunrise Manufacture Group Co., Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd.

Xiwang Group

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Type

Fillers

Lubricants

Binders

Disintegrants

Coating Materials

Other

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Application

Tablets

Granules and Powders

Capsules

Pharmaceutical Excipients for Oral Solid Dosage Forms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients for Oral Solid Dosage Forms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients for Oral Solid Dosage Forms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients for Oral Solid Dosage Forms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipients for Oral Solid Dosage Forms manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharmaceutical Excipients for Oral Solid Dosage Forms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fillers Table 2. Major Company of Lubricants Table 3. Major Company of Binders Table 4. Major Company of Disintegrants Table 5. Major Company of Coating Materials Table 6. Major Company of Other Table 7. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 9. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type (2021-2026) Table 10. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 11. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type (2021-2026) Table 12. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2021-2026) & (USD/t) Table 13. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (t) Table 14. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type (2027-2032) Table 15. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2027-2032) & (US$ Million) Table 16. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type (2027-2032) Table 17. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Type (2027-2032) & (USD/t) Table 18. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 19. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 21. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 23. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 25. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (t) Table 27. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Type (2021-2026) & (US$ Million) Table 28. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends Table 29. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers Table 30. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges Table 31. Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints Table 32. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue Market Share by Company (2021-2026) Table 34. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Company (2021-2026) & (t) Table 35. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Company (2021-2026) Table 36. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Price by Company (2021-2026) & (USD/t) Table 37. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Major Company Production Sites and Headquarters Table 39. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Company, Product Type & Application Table 40. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Pharmaceutical Excipients for Oral Solid Dosage Forms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026) & (t) Table 45. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Region (2021-2026) Table 46. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2021-2026) & (US$ Million) Table 47. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Region (2021-2026) Table 48. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 49. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2027-2032) & (t) Table 50. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Region (2027-2032) Table 51. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Region (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Region (2027-2032) Table 53. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 54. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 56. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application (2021-2026) Table 57. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 58. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application (2021-2026) Table 59. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2021-2026) & (USD/t) Table 60. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (t) Table 61. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application (2027-2032) Table 62. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2027-2032) & (US$ Million) Table 63. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application (2027-2032) Table 64. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Price by Application (2027-2032) & (USD/t) Table 65. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 66. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 68. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 70. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 72. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (t) Table 74. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Application (2021-2026) & (US$ Million) Table 75. Ashland Company Information Table 76. Ashland Business Overview Table 77. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 79. Ashland Recent Development Table 80. Associated British Foods Company Information Table 81. Associated British Foods Business Overview Table 82. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 84. Associated British Foods Recent Development Table 85. BASF Company Information Table 86. BASF Business Overview Table 87. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 89. BASF Recent Development Table 90. Croda International Company Information Table 91. Croda International Business Overview Table 92. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 94. Croda International Recent Development Table 95. Dow Company Information Table 96. Dow Business Overview Table 97. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 99. Dow Recent Development Table 100. Evonik Company Information Table 101. Evonik Business Overview Table 102. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 104. Evonik Recent Development Table 105. JRS Pharma Company Information Table 106. JRS Pharma Business Overview Table 107. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 109. JRS Pharma Recent Development Table 110. Lubrizol Company Information Table 111. Lubrizol Business Overview Table 112. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 114. Lubrizol Recent Development Table 115. Mitsubishi Company Information Table 116. Mitsubishi Business Overview Table 117. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 119. Mitsubishi Recent Development Table 120. Roquette Company Information Table 121. Roquette Business Overview Table 122. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 124. Roquette Recent Development Table 125. Shin-Etsu Company Information Table 126. Shin-Etsu Business Overview Table 127. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 129. Shin-Etsu Recent Development Table 130. Südzucker AG Company Information Table 131. Südzucker AG Business Overview Table 132. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 133. Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 134. Südzucker AG Recent Development Table 135. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 136. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 137. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 138. Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 139. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 140. Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information Table 141. Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview Table 142. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 143. Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 144. Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Development Table 145. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information Table 146. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview Table 147. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 148. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 149. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Development Table 150. Sunrise Manufacture Group Co., Ltd. Company Information Table 151. Sunrise Manufacture Group Co., Ltd. Business Overview Table 152. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 153. Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 154. Sunrise Manufacture Group Co., Ltd. Recent Development Table 155. Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information Table 156. Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview Table 157. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 158. Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 159. Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Development Table 160. Xiwang Group Company Information Table 161. Xiwang Group Business Overview Table 162. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 163. Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio Table 164. Xiwang Group Recent Development Table 165. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 166. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 167. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2026) Table 168. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032) & (t) Table 169. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share Forecast by Country (2027-2032) Table 170. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026) & (US$ Million) Table 172. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country (2021-2026) Table 173. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share Forecast by Country (2027-2032) Table 175. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 176. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 177. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2026) Table 178. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032) & (t) Table 179. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share Forecast by Country (2027-2032) Table 180. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026) & (US$ Million) Table 182. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country (2021-2026) Table 183. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share Forecast by Country (2027-2032) Table 185. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 186. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 187. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2026) Table 188. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032) & (t) Table 189. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share Forecast by Country (2027-2032) Table 190. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026) & (US$ Million) Table 192. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country (2021-2026) Table 193. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share Forecast by Country (2027-2032) Table 195. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 196. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 197. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2026) Table 198. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032) & (t) Table 199. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share Forecast by Country (2027-2032) Table 200. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026) & (US$ Million) Table 202. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country (2021-2026) Table 203. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share Forecast by Country (2027-2032) Table 205. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 206. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026) & (t) Table 207. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share by Country (2021-2026) Table 208. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032) & (t) Table 209. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share Forecast by Country (2027-2032) Table 210. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026) & (US$ Million) Table 212. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country (2021-2026) Table 213. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share Forecast by Country (2027-2032) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors List Table 218. Pharmaceutical Excipients for Oral Solid Dosage Forms Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients for Oral Solid Dosage Forms Image Figure 2. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2032) & (t) Figure 5. Fillers Image Figure 6. Global Fillers Sales YoY Growth (2021-2032) & (t) Figure 7. Lubricants Image Figure 8. Global Lubricants Sales YoY Growth (2021-2032) & (t) Figure 9. Binders Image Figure 10. Global Binders Sales YoY Growth (2021-2032) & (t) Figure 11. Disintegrants Image Figure 12. Global Disintegrants Sales YoY Growth (2021-2032) & (t) Figure 13. Coating Materials Image Figure 14. Global Coating Materials Sales YoY Growth (2021-2032) & (t) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (t) Figure 17. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Type 2025 VS 2032 Figure 19. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type in 2025 Figure 20. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type in 2025 Figure 21. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type in 2025 Figure 22. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type in 2025 Figure 25. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Pharmaceutical Excipients for Oral Solid Dosage Forms Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Tablets Image Figure 32. Global Tablets Sales YoY Growth (2021-2032) & (t) Figure 33. Granules and Powders Image Figure 34. Global Granules and Powders Sales YoY Growth (2021-2032) & (t) Figure 35. Capsules Image Figure 36. Global Capsules Sales YoY Growth (2021-2032) & (t) Figure 37. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Application 2025 VS 2032 Figure 39. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application in 2025 Figure 40. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application in 2025 Figure 41. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application in 2025 Figure 42. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application in 2025 Figure 45. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Market Share in Value by Application in 2025 Figure 49. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 66. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Fillers
  • Lubricants
  • Binders
  • Disintegrants
  • Coating Materials
  • Other
Applications
  • Tablets
  • Granules and Powders
  • Capsules
Companies covered
  • Ashland
  • Associated British Foods
  • BASF
  • Croda International
  • Dow
  • Evonik
  • JRS Pharma
  • Lubrizol
  • Mitsubishi
  • Roquette
  • Shin-Etsu
  • Südzucker AG
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Tianjin Chasesun Pharmaceutical Co., Ltd.
  • Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  • Sunrise Manufacture Group Co., Ltd.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.
  • Xiwang Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Type
  6. 1.3.1 Fillers
  7. 1.3.2 Lubricants
  8. 1.3.3 Binders
  9. 1.3.4 Disintegrants
  10. 1.3.5 Coating Materials
  11. 1.3.6 Other
  12. 1.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Type
  13. 1.4.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Trends
  2. 2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Drivers
  3. 2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharmaceutical Excipients for Oral Solid Dosage Forms Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (2021-2026)
  3. 3.3 Global Top Players by Pharmaceutical Excipients for Oral Solid Dosage Forms Price (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Major Company Production Sites & Headquarters
  6. 3.6 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Company, Product Type & Application
  7. 3.7 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Excipients for Oral Solid Dosage Forms Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Excipients for Oral Solid Dosage Forms Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Excipients for Oral Solid Dosage Forms Regional Status and Outlook
  1. 4.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Historic Market Size by Region
  3. 4.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Forecasted Market Size by Region
  7. 4.3.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharmaceutical Excipients for Oral Solid Dosage Forms by Application
  1. 5.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Granules and Powders
  4. 5.1.3 Capsules
  5. 5.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Application
  6. 5.2.1 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pharmaceutical Excipients for Oral Solid Dosage Forms Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ashland
  2. 6.1.1 Ashland Company Information
  3. 6.1.2 Ashland Business Overview
  4. 6.1.3 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ashland Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  6. 6.1.5 Ashland Recent Developments
  7. 6.2 Associated British Foods
  8. 6.2.1 Associated British Foods Company Information
  9. 6.2.2 Associated British Foods Business Overview
  10. 6.2.3 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Associated British Foods Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  12. 6.2.5 Associated British Foods Recent Developments
  13. 6.3 BASF
  14. 6.3.1 BASF Company Information
  15. 6.3.2 BASF Business Overview
  16. 6.3.3 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BASF Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  18. 6.3.5 BASF Recent Developments
  19. 6.4 Croda International
  20. 6.4.1 Croda International Company Information
  21. 6.4.2 Croda International Business Overview
  22. 6.4.3 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Croda International Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  24. 6.4.5 Croda International Recent Developments
  25. 6.5 Dow
  26. 6.5.1 Dow Company Information
  27. 6.5.2 Dow Business Overview
  28. 6.5.3 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dow Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  30. 6.5.5 Dow Recent Developments
  31. 6.6 Evonik
  32. 6.6.1 Evonik Company Information
  33. 6.6.2 Evonik Business Overview
  34. 6.6.3 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Evonik Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  36. 6.6.5 Evonik Recent Developments
  37. 6.7 JRS Pharma
  38. 6.7.1 JRS Pharma Company Information
  39. 6.7.2 JRS Pharma Business Overview
  40. 6.7.3 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 JRS Pharma Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  42. 6.7.5 JRS Pharma Recent Developments
  43. 6.8 Lubrizol
  44. 6.8.1 Lubrizol Company Information
  45. 6.8.2 Lubrizol Business Overview
  46. 6.8.3 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lubrizol Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  48. 6.8.5 Lubrizol Recent Developments
  49. 6.9 Mitsubishi
  50. 6.9.1 Mitsubishi Company Information
  51. 6.9.2 Mitsubishi Business Overview
  52. 6.9.3 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mitsubishi Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  54. 6.9.5 Mitsubishi Recent Developments
  55. 6.10 Roquette
  56. 6.10.1 Roquette Company Information
  57. 6.10.2 Roquette Business Overview
  58. 6.10.3 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Roquette Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  60. 6.10.5 Roquette Recent Developments
  61. 6.11 Shin-Etsu
  62. 6.11.1 Shin-Etsu Company Information
  63. 6.11.2 Shin-Etsu Business Overview
  64. 6.11.3 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shin-Etsu Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  66. 6.11.5 Shin-Etsu Recent Developments
  67. 6.12 Südzucker AG
  68. 6.12.1 Südzucker AG Company Information
  69. 6.12.2 Südzucker AG Business Overview
  70. 6.12.3 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Südzucker AG Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  72. 6.12.5 Südzucker AG Recent Developments
  73. 6.13 Hunan Er-Kang Pharmaceutical Co., Ltd.
  74. 6.13.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  78. 6.13.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Tianjin Chasesun Pharmaceutical Co., Ltd.
  80. 6.14.1 Tianjin Chasesun Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Tianjin Chasesun Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Tianjin Chasesun Pharmaceutical Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  84. 6.14.5 Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
  86. 6.15.1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Company Information
  87. 6.15.2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Business Overview
  88. 6.15.3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  90. 6.15.5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Recent Developments
  91. 6.16 Sunrise Manufacture Group Co., Ltd.
  92. 6.16.1 Sunrise Manufacture Group Co., Ltd. Company Information
  93. 6.16.2 Sunrise Manufacture Group Co., Ltd. Business Overview
  94. 6.16.3 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sunrise Manufacture Group Co., Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  96. 6.16.5 Sunrise Manufacture Group Co., Ltd. Recent Developments
  97. 6.17 Nanjing Well Pharmaceutical Group Co.,Ltd.
  98. 6.17.1 Nanjing Well Pharmaceutical Group Co.,Ltd. Company Information
  99. 6.17.2 Nanjing Well Pharmaceutical Group Co.,Ltd. Business Overview
  100. 6.17.3 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Nanjing Well Pharmaceutical Group Co.,Ltd. Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  102. 6.17.5 Nanjing Well Pharmaceutical Group Co.,Ltd. Recent Developments
  103. 6.18 Xiwang Group
  104. 6.18.1 Xiwang Group Company Information
  105. 6.18.2 Xiwang Group Business Overview
  106. 6.18.3 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Xiwang Group Pharmaceutical Excipients for Oral Solid Dosage Forms Product Portfolio
  108. 6.18.5 Xiwang Group Recent Developments
7 North America by Country
  1. 7.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country
  2. 7.1.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026)
  4. 7.1.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  6. 7.2.1 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country
  2. 8.1.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  6. 8.2.1 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country
  2. 9.1.1 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  6. 9.2.1 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country
  2. 10.1.1 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026)
  4. 10.1.3 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  6. 10.2.1 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country
  2. 11.1.1 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country
  6. 11.2.1 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharmaceutical Excipients for Oral Solid Dosage Forms Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Value Chain Analysis
  2. 12.1.1 Pharmaceutical Excipients for Oral Solid Dosage Forms Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharmaceutical Excipients for Oral Solid Dosage Forms Production Mode & Process
  7. 12.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharmaceutical Excipients for Oral Solid Dosage Forms Distributors
  10. 12.2.3 Pharmaceutical Excipients for Oral Solid Dosage Forms Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst